HCPCS Code Descriptor:
Injection, lanreotide, (cipla), 1 mg
Route of Administration:
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
Lanreotide is an Oncology drug manufactured by Cipla and administered via the Subcutaneous route of administration. The J Code: J1932 is aligned to the drug Lanreotide.